Vitrolife AB 2020 AR2
The report highlights Vitrolife's performance during the 2020 fiscal year, which was significantly impacted by the Covid-19 pandemic. Despite a 13% decrease in sales in local currencies to SEK 1,246 million, the company maintained profitability with an EBITDA margin of 36%. Key sustainability achievements included obtaining Nasdaq ESG Transparency Partner certification, conducting a life-cycle analysis of EmbryoScope+, and beginning to track carbon dioxide emissions in accordance with the GHG Protocol. Additionally, Vitrolife established a new executive management position focused on sustainability and successfully adapted to digital customer support and remote working.
Company: Vitrolife AB
Sector: Health Care
Country: Sweden
Year: 2020
Type: AR2
Pages: 68
Vitrolife AB
Annual Report
The report highlights Vitrolife's performance during the 2020 fiscal year, which was significantly impacted by the Covid-19 pandemic. Despite a 13% decrease in sales in local currencies to SEK 1,246 million, the company maintained profitability with an EBITDA margin of 36%. Key sustainability achievements included obtaining Nasdaq ESG Transparency Partner certification, conducting a life-cycle analysis of EmbryoScope+, and beginning to track carbon dioxide emissions in accordance with the GHG Protocol. Additionally, Vitrolife established a new executive management position focused on sustainability and successfully adapted to digital customer support and remote working.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Women on Board
Women in Management
Employees